1. Hao, Yong-Ping, Wang, Wen-Yi, Qiao, Qiao, Li, Guang. . EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. In Medicine, 100, e26188. doi:10.1097/MD.0000000000026188. https://pubmed.ncbi.nlm.nih.gov/34087884/
2. Calaf, Gloria M, Roy, Debasish, Jara, Lilian, Aguayo, Francisco, Crispin, Leodan A. 2023. Gene Signature Associated with Nervous System in an Experimental Radiation- and Estrogen-Induced Breast Cancer Model. In Biomedicines, 11, . doi:10.3390/biomedicines11123111. https://pubmed.ncbi.nlm.nih.gov/38137332/
3. Zhang, Yongqiang, Zhang, Jinning, Pan, Guanlong, Li, Yan, Ren, Hai. 2021. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma. In World journal of surgical oncology, 19, 242. doi:10.1186/s12957-021-02362-8. https://pubmed.ncbi.nlm.nih.gov/34399788/
4. Tian, Ye, Ma, Guochen, Li, Haoqi, Xiong, Jingyuan, Cheng, Guo. 2023. Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease. In Movement disorders : official journal of the Movement Disorder Society, 38, 1813-1821. doi:10.1002/mds.29572. https://pubmed.ncbi.nlm.nih.gov/37534731/
5. Cui, Yun, Chang, Yongxia, Ma, Xixi, Xie, Shanshan, Zhou, Tianhua. . Ephrin A1 Stimulates CCL2 Secretion to Facilitate Premetastatic Niche Formation and Promote Gastric Cancer Liver Metastasis. In Cancer research, 85, 263-276. doi:10.1158/0008-5472.CAN-24-1254. https://pubmed.ncbi.nlm.nih.gov/39412948/
6. Shen, Xiaopeng, Li, Meng, Lei, Yang, Bi, Chao, Zhu, Guoping. 2022. An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer. In Human cell, 35, 705-720. doi:10.1007/s13577-022-00679-4. https://pubmed.ncbi.nlm.nih.gov/35072898/
7. Han, Baoai, Zhang, He, Tian, Ruinan, Niu, Ruifang, Zhang, Fei. 2022. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. In Theranostics, 12, 4127-4146. doi:10.7150/thno.72404. https://pubmed.ncbi.nlm.nih.gov/35673569/
8. Xie, Fei, Qiu, Jinrong, Sun, Congyong, Zhang, Li, Wang, Qilong. 2024. Development of a Specific Aptamer-Modified Nano-System to Treat Esophageal Squamous Cell Carcinoma. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2309084. doi:10.1002/advs.202309084. https://pubmed.ncbi.nlm.nih.gov/38704694/
9. Jiang, Houxiang, Wang, Shaoxiang, Liu, Ying, Liu, Kaisheng, Ma, Xiaoshi. 2023. Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. In Discover oncology, 14, 64. doi:10.1007/s12672-023-00664-9. https://pubmed.ncbi.nlm.nih.gov/37160815/